OpenFilings

Spyre Therapeutics, Inc.

Form10-K/A

Report Period2023-12-31

Date Filed2024-03-01

Time Filed06:14:57

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K/A
EX-31.1
EX-31.2
Filing on SEC Edgar